Neutrexin
Active Ingredient(s): TrimetrexateFDA Approved: * December 17, 1993
Pharm Company: * MEDIMMUNE ONCOLOGY
Category: Immune System
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Neutrexin Overview
Trimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.[1] Uses It has been used with leucovorin in treating pneumocystis pneumonia.[2] It has been investigated for use in treating leiomyosarcoma.[3] It is a methotrexate (MTX) analog that is active against transport-deficient MTX-resistant tumor cells that overcome the acquired and natural resistance to methotrexate. Other uses include skin lymphoma. [4&a...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Trimetrexate
Recent Neutrexin Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Trimetrexate
- Injection: 200mg, 200mg/vial, 25mg, 25mg/vial